INTRODUCTION: Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. METHODS: We undertook a test negative case control study to estimate the overall and age-specific (6 months-17 years, 18-64 years, ≥65 years old) IVE against medically attended POCT-confirmed influenza. The study took place over the winter of 2019-2020 and was nested within twelve general practices that are part of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), the English sentinel surveillance network. RESULTS: 648 POCT were conducted. 193 (29.7%) of those who were swabbed had received the seasonal influenza vaccine. The crude unadjusted overall IVE was 46.1% (95% CI: 13.9-66.3). After adjusting for confounders the overall IVE was 26.0% (95% CI: 0-65.5). In total 211 patients were prescribed an antimicrobial after swab testing. Given a positive influenza POCT result, the odds ratio (OR) of receiving an antiviral was 21.1 (95%CI: 2.4-182.2, p = <0.01) and the OR of being prescribed an antibiotic was 0.6 (95%CI: 0.4-0.9, p = <0.01). DISCUSSION: Using influenza POCT in a primary care sentinel surveillance network to estimate IVE is feasible and provides comparable results to published IVE estimates. A further advantage is that near patient testing of influenza is associated with improvements in appropriate antiviral and antibiotic use. Larger, randomised studies are needed in primary care to see if these trends are still present and to explore their impact on outcomes.
INTRODUCTION: Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. METHODS: We undertook a test negative case control study to estimate the overall and age-specific (6 months-17 years, 18-64 years, ≥65 years old) IVE against medically attended POCT-confirmed influenza. The study took place over the winter of 2019-2020 and was nested within twelve general practices that are part of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), the English sentinel surveillance network. RESULTS: 648 POCT were conducted. 193 (29.7%) of those who were swabbed had received the seasonal influenza vaccine. The crude unadjusted overall IVE was 46.1% (95% CI: 13.9-66.3). After adjusting for confounders the overall IVE was 26.0% (95% CI: 0-65.5). In total 211 patients were prescribed an antimicrobial after swab testing. Given a positive influenza POCT result, the odds ratio (OR) of receiving an antiviral was 21.1 (95%CI: 2.4-182.2, p = <0.01) and the OR of being prescribed an antibiotic was 0.6 (95%CI: 0.4-0.9, p = <0.01). DISCUSSION: Using influenza POCT in a primary care sentinel surveillance network to estimate IVE is feasible and provides comparable results to published IVE estimates. A further advantage is that near patient testing of influenza is associated with improvements in appropriate antiviral and antibiotic use. Larger, randomised studies are needed in primary care to see if these trends are still present and to explore their impact on outcomes.
Authors: Harshana Liyanage; Oluwafunmi Akinyemi; Sameera Pathirannahelage; Mark Joy; Simon de Lusignan Journal: Stud Health Technol Inform Date: 2020-06-16
Authors: Simon de Lusignan; Uy Hoang; Harshana Liyanage; Manasa Tripathy; Ivelina Yonova; Rachel Byford; Filipa Ferreira; Javier Diez-Domingo; Tristan Clark Journal: Br J Gen Pract Date: 2020-07-30 Impact factor: 5.386
Authors: Lauren C Ramsay; Sarah A Buchan; Robert G Stirling; Benjamin J Cowling; Shuo Feng; Jeffrey C Kwong; Bryna F Warshawsky Journal: BMC Med Date: 2019-01-10 Impact factor: 8.775
Authors: Fatimah S Dawood; Jessie R Chung; Sara S Kim; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kayan Dunnigan; Angie Foust; Wendy Sessions; Juliana DaSilva; Shoshona Le; Thomas Stark; Rebecca J Kondor; John R Barnes; David E Wentworth; Lynnette Brammer; Alicia M Fry; Manish M Patel; Brendan Flannery Journal: MMWR Morb Mortal Wkly Rep Date: 2020-02-21 Impact factor: 17.586
Authors: Ana Correa; William Hinton; Andrew McGovern; Jeremy van Vlymen; Ivelina Yonova; Simon Jones; Simon de Lusignan Journal: BMJ Open Date: 2016-04-20 Impact factor: 2.692
Authors: Joseph Jonathan Lee; Jan Y Verbakel; Clare Rosemary Goyder; Thanusha Ananthakumar; Pui San Tan; Phillip James Turner; Gail Hayward; Ann Van den Bruel Journal: Clin Infect Dis Date: 2019-06-18 Impact factor: 9.079
Authors: Laura M Vos; Andrea H L Bruning; Johannes B Reitsma; Rob Schuurman; Annelies Riezebos-Brilman; Andy I M Hoepelman; Jan Jelrik Oosterheert Journal: Clin Infect Dis Date: 2019-09-13 Impact factor: 9.079